Catecholamine physiology and its implications in patients with COVID-19.
Journal
The lancet. Diabetes & endocrinology
ISSN: 2213-8595
Titre abrégé: Lancet Diabetes Endocrinol
Pays: England
ID NLM: 101618821
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
21
08
2020
revised:
21
09
2020
accepted:
23
09
2020
pubmed:
1
11
2020
medline:
15
12
2020
entrez:
31
10
2020
Statut:
ppublish
Résumé
The risk factors for severe COVID-19 are diverse, yet closely resemble the clinical manifestations of catecholamine excess states (eg, hypertension, cardiovascular disease, immune dysregulation, and hyperglycaemia), suggesting a potentially common basis for disease. Unfortunately, severe illness (eg, respiratory failure, compromised cardiac function, and shock) incurred by COVID-19 hinders the direct study of catecholamines in these patients, especially among those on multiple medications or those on adrenaline or noradrenaline infusions, or both. Phaeochromocytoma and paraganglioma (PPGL) are tumours that secrete catecholamines, namely adrenaline and noradrenaline, often in excess. PPGL are well studied disease processes in which the effects of catecholamines are easily discernible and therefore their potential biochemical and physiological influences in patients with COVID-19 can be explored. Because catecholamines are expected to have a role in patients with critical illness, patients on vasopressor infusions, and patients who sustain some acute and chronic physical stresses, the challenges involved in the management of catecholamine excess states are directly relevant to the treatment of patients with COVID-19. In this Personal View, we discuss the complex interplay between catecholamines and COVID-19, and the management of catecholamine excess states, while referencing relevant insights derived from the study of PPGL.
Identifiants
pubmed: 33128872
pii: S2213-8587(20)30342-9
doi: 10.1016/S2213-8587(20)30342-9
pmc: PMC7598304
pii:
doi:
Substances chimiques
Catecholamines
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
978-986Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Références
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
J Hypertens. 2011 Nov;29(11):2049-60
pubmed: 21826022
J Clin Endocrinol Metab. 2020 Jul 1;105(7):
pubmed: 31714582
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nat Rev Dis Primers. 2020 Jul 15;6(1):60
pubmed: 32669623
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Clin Endocrinol (Oxf). 1983 Jan;18(1):37-41
pubmed: 6303636
Cell Signal. 1989;1(5):483-92
pubmed: 2561913
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
N Engl J Med. 2018 Mar 15;378(11):1043-1053
pubmed: 29539275
Endocr Pract. 2008 Dec;14(9):1137-49
pubmed: 19158054
Circ Res. 2020 May 8;126(10):1456-1474
pubmed: 32264791
J Med Case Rep. 2019 Jan 5;13(1):3
pubmed: 30609924
Lancet Diabetes Endocrinol. 2020 Aug;8(8):659-660
pubmed: 32563278
Prog Cardiovasc Dis. 2020 Jan - Feb;63(1):10-21
pubmed: 31759953
Physiol Rev. 2012 Jan;92(1):367-520
pubmed: 22298659
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3
pubmed: 32369736
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
J Exp Med. 1997 Mar 17;185(6):1143-8
pubmed: 9091588
Crit Care. 2020 Apr 16;24(1):154
pubmed: 32299472
J Med Virol. 2020 Jul;92(7):814-818
pubmed: 32253759
Clin Endocrinol (Oxf). 2015 Nov;83(5):622-8
pubmed: 25940577
Lancet. 2020 May 2;395(10234):1407-1409
pubmed: 32278362
Horm Metab Res. 2019 Jul;51(7):458-469
pubmed: 30227459
Am J Geriatr Psychiatry. 2013 Dec;21(12):1190-222
pubmed: 24206937
Physiol Rev. 1990 Oct;70(4):963-85
pubmed: 1977182
Intensive Care Med. 2020 Jun;46(6):1099-1102
pubmed: 32291463
N Engl J Med. 2019 Mar 28;380(13):1284-1286
pubmed: 30917266
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E736-E741
pubmed: 32228322
N Engl J Med. 2005 Oct 20;353(16):1711-23
pubmed: 16236742
JAMA. 2020 Jun 23;323(24):2518-2520
pubmed: 32437497
Neuroimmunomodulation. 2007;14(1):57-64
pubmed: 17700041
J Clin Endocrinol Metab. 2017 Apr 1;102(4):1208-1217
pubmed: 28001459
Am J Hypertens. 2020 Apr 29;33(5):373-374
pubmed: 32251498
Clin Endocrinol (Oxf). 2015 Sep;83(3):298-302
pubmed: 25683095
Ann Intern Med. 2020 Aug 18;173(4):268-277
pubmed: 32374815
Eur J Pediatr. 1989 Jan;148(4):286-93
pubmed: 2651128
Curr Med Chem. 2006;13(17):1979-89
pubmed: 16842192
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Neuroimmunomodulation. 2007;14(6):344-53
pubmed: 18463421
J Clin Invest. 2020 Jul 1;130(7):3345-3347
pubmed: 32352407
Signal Transduct Target Ther. 2020 Mar 27;5(1):33
pubmed: 32296069
Eur J Endocrinol. 2019 Oct;181(4):409-420
pubmed: 31370000
Nat Rev Immunol. 2020 May;20(5):269-270
pubmed: 32273594
Lancet Infect Dis. 2020 Dec;20(12):1365-1366
pubmed: 32359410
Front Immunol. 2020 Jun 16;11:1441
pubmed: 32612615
Am J Physiol Heart Circ Physiol. 2003 Feb;284(2):H619-25
pubmed: 12388296
J Clin Endocrinol Metab. 2001 Dec;86(12):5920-4
pubmed: 11739465
N Engl J Med. 2019 Aug 8;381(6):552-565
pubmed: 31390501
J Am Coll Cardiol. 2020 Jul 28;76(4):451-464
pubmed: 32703516
Pharmacol Rev. 2004 Sep;56(3):331-49
pubmed: 15317907
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
N Engl J Med. 2020 Jul 23;383(4):347-358
pubmed: 32598830
Science. 1984 May 4;224(4648):452-9
pubmed: 6143403
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
J Am Heart Assoc. 2020 Apr 7;9(7):e016219
pubmed: 32233755
JAMA Netw Open. 2020 Apr 1;3(4):e205619
pubmed: 32275319
Lancet. 2005 Aug 20-26;366(9486):665-75
pubmed: 16112304
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
JAMA Cardiol. 2020 Jul 1;5(7):745-747
pubmed: 32242890
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5170-5180
pubmed: 31009053
Prog Brain Res. 2008;167:229-37
pubmed: 18037018
Cardiovasc Res. 2001 Feb 1;49(2):476-83
pubmed: 11164858
Nature. 2018 Dec;564(7735):273-277
pubmed: 30542164
J Clin Endocrinol Metab. 2007 Nov;92(11):4069-79
pubmed: 17989126
JAMA. 2020 Jun 9;323(22):2329-2330
pubmed: 32329799
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
J Immunol. 2002 Jun 15;168(12):6128-35
pubmed: 12055224
N Engl J Med. 2020 Jul 17;:
pubmed: 32678530
Mayo Clin Proc. 1981 Jun;56(6):354-60
pubmed: 6453259
J Clin Endocrinol Metab. 2003 Jun;88(6):2656-66
pubmed: 12788870
Circulation. 2020 Aug 4;142(5):429-436
pubmed: 32418446
Mod Pathol. 2020 Jun;33(6):1007-1014
pubmed: 32291399
Eur J Endocrinol. 2020 Aug;183(2):G79-G88
pubmed: 32554825
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833
pubmed: 32798471
Brain Behav Immun. 2012 Feb;26(2):195-200
pubmed: 21855626
N Engl J Med. 2020 Apr 23;382(17):1653-1659
pubmed: 32227760
Endocrinology. 2020 Oct 1;161(10):
pubmed: 32603424